45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
18,264
Insurances with rates
9
CPT / HCPCS codes
12,091
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| A9547 | IN-111 OXYQUINOLONE [40859015] | $348,285 | $139,314 | — | — | 0 |
| A9542 | IN-111 IBRITUMOMAB,DX [40859014] | $322,350 | $128,940 | — | — | 0 |
| J9347 | TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION [187437] | $292,500 | $117,000 | — | — | 0 |
| J9600 | PORFIMER 75 MG INTRAVENOUS SOLUTION [14472] | $255,338 | $102,135 | — | — | 0 |
| J1303 | RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION [168453] | $176,110 | $70,444 | — | — | 0 |
| J0202 | ALEMTUZUMAB 12 MG/1.2 ML INTRAVENOUS SOLUTION [127653] | $143,150 | $57,260 | — | — | 0 |
| J9247 | MELPHALAN FLUFENAMIDE 20 MG INTRAVENOUS SOLUTION [515173] | $142,500 | $57,000 | — | — | 0 |
| 27807330_J7330_278 | Hc Autologous Cultured Chondrocytes, Implant | $140,428 | $56,171 | — | — | 0 |
| J2507 | PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION [107664] | $116,146 | $46,458 | — | — | 0 |
| J9298 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION [185464] | $111,746 | $44,698 | — | — | 0 |
| J2350 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION [170113] | $101,563 | $40,625 | — | — | 0 |
| A9596 | GALLIUM GA-68 GOZETOTIDE (ILLUCIX) [4089596] | $94,000 | $37,600 | — | — | 0 |
| 62400022_624 | Hc *Irb* Clasp Ii D Syst Transcath Mitral Valve Repair Syst Implant Syst | $87,500 | $35,000 | — | — | 0 |
| 62400025_624 | Hc *Irb* Clasp Tr Pascal System | $87,500 | $35,000 | — | — | 0 |
| 62400042_624 | Hc *Irb* Jenavalve Aortic Pericardial Transcatheter Heart Valve | $87,500 | $35,000 | — | — | 0 |
| J1290 | ECALLANTIDE 10 MG/ML (1 ML) SUBCUTANEOUS SOLUTION [100698] | $86,163 | $34,465 | — | — | 0 |
| J9272 | DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION [182661] | $80,911 | $32,364 | — | — | 0 |
| J9353 | MARGETUXIMAB-CMKB 25 MG/ML INTRAVENOUS SOLUTION [179701] | $78,513 | $31,405 | — | — | 0 |
| J9043 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION [105644] | $76,369 | $30,548 | — | — | 0 |
| 62400048_624 | Hc *Irb* Progress Study Sapien 3 Thv & Ultra Thv System | $75,000 | $30,000 | — | — | 0 |
| J9223 | LURBINECTEDIN 4 MG INTRAVENOUS SOLUTION [181196] | $73,378 | $29,351 | — | — | 0 |
| J0791 | CRIZANLIZUMAB-TMCA 10 MG/ML INTRAVENOUS SOLUTION [179351] | $70,813 | $28,325 | — | — | 0 |
| J9119 | CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION [176111] | $68,250 | $27,300 | — | — | 0 |
| J9228 | IPILIMUMAB 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION [108955] | $68,185 | $27,274 | — | — | 0 |
| J1930 | LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE [87861] | $66,695 | $26,678 | — | — | 0 |
| J9358 | FAM-TRASTUZUMAB DERUXTECAN-NXKI 100 MG INTRAVENOUS SOLUTION [179861] | $66,297 | $26,519 | — | — | 0 |
| 27801824_C1824_278 | Hc Cardiac Contractility Modulation Generator Impl | $65,000 | $26,000 | — | — | 0 |
| 81100000 | Hc Liv Donor Kidney | $64,944 | $25,978 | — | — | 0 |
| 81200000 | Hc Cadvr Donor Kidny | $64,944 | $25,978 | — | — | 0 |
| 27801604_C1604_278 | Noncdm Charge Record Medical Supplies | $62,500 | $25,000 | — | — | 0 |
| J9144 | DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN [180990] | $61,804 | $24,722 | — | — | 0 |
| J9317 | SACITUZUMAB GOVITECAN-HZIY 180 MG INTRAVENOUS SOLUTION [180589] | $59,705 | $23,882 | — | — | 0 |
| A9509 | I-123 IODIDE SOLUTION [40859011] | $58,065 | $23,226 | — | — | 0 |
| C9047 | CAPLACIZUMAB-YHDP 11 MG INJECTION KIT [177088] | $56,940 | $22,776 | — | — | 0 |
| J3101 | TENECTEPLASE 50 MG INTRAVENOUS SOLUTION [173754] | $55,337 | $22,135 | — | — | 0 |
| 62400061_624 | Hc *Irb* Envision Navitor Transcatheter Aortic Valve | $55,313 | $22,125 | — | — | 0 |
| 62400063_624 | Hc *Irb* Persevere Amds Ide Hybrid Prosthesis And Tapered | $55,000 | $22,000 | — | — | 0 |
| 27200169 | Hc Tademlife (Ecmo) | $54,825 | $21,930 | — | — | 0 |
| J9210 | EMAPALUMAB-LZSG 5 MG/ML INTRAVENOUS SOLUTION [176987] | $54,330 | $21,732 | — | — | 0 |
| J9311 | RITUXIMAB 1,400 MG/11.7 ML (120 MG/ML)-HYALURONIDASE SUBCUTANEOUS SOLN [170215] | $53,665 | $21,466 | — | — | 0 |
| 27801822_C1822_278 | Noncdm Charge Record Medical Supplies | $52,318 | $20,927 | — | — | 0 |
| J9022 | ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) INTRAVENOUS SOLUTION [177392] | $51,487 | $20,595 | — | — | 0 |
| J9063 | MIRVETUXIMAB SORAVTANSINE-GYNX 5 MG/ML INTRAVENOUS SOLUTION [187494] | $50,756 | $20,302 | — | — | 0 |
| J2323 | NATALIZUMAB 300 MG/15 ML INTRAVENOUS SOLUTION [40120] | $50,429 | $20,172 | — | — | 0 |
| J9273 | TISOTUMAB VEDOTIN-TFTV 40 MG INTRAVENOUS SOLUTION [184033] | $49,493 | $19,797 | — | — | 0 |
| J9145 | DARATUMUMAB 20 MG/ML INTRAVENOUS SOLUTION [133971] | $48,935 | $19,574 | — | — | 0 |
| 48133991 | Hc Insert Vad Art/Vein Access W/Si | $48,800 | $19,520 | — | — | 0 |
| J3285 | TREPROSTINIL SODIUM 5 MG/ML INJECTION SOLUTION [32933] | $48,705 | $19,482 | — | — | 0 |
| J7168 | HUM PROTHROMBIN CPLX (PCC) 4FACTOR 500 UNIT (400-620 UNIT) IV SOLUTION [132765] | $48,020 | $19,208 | — | — | 0 |
| J1300 | ECULIZUMAB 300 MG/30 ML INTRAVENOUS SOLUTION [81696] | $48,010 | $19,204 | — | — | 0 |
Showing top 50 of 18,264 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.